Edit |   |
---|---|
Antigenic Specificity | CD266, Human (Enavatuzumab biosimilar) |
Clone | Enavatuzumab |
Host Species | Recombinant |
Reactive Species | human |
Isotype | IgG1 kappa |
Format | purified |
Size | 1mg, 5mg |
Concentration | 1mg/ml |
Applications | n/a |
Reviews / Ratings | If you have used this antibody, please help fellow researchers by submitting reviews to pAbmAbs and antYbuddY. |
Description | Anti-Human CD266 Recombinant Antibody. Enavatuzumab is a humanized monoclonal antibody used in the treatment of solid tumors.Enavatuzumab was developed by Facet Biotech Corp. |
Immunogen | n/a |
Other Names | Anti-CD266 Recombinant Antibody, Research Grade Enavatuzumab, Anti-Human CD266 Recombinant Antibody, PDL 192, Antibody Drug Analogues, Monoclonal Antibody, YR1240, Research Grade Biosimilars, Biosimilar Antibody |
Gene, Accession # | CAS: 1062149-33-0 |
Catalog # | YR1240 |
Price | please inquire |
Order / More Info | CD266, Human (Enavatuzumab biosimilar) Antibody from KMD BIOSCIENCE CO. LTD. |
Product Specific References | n/a |